Krishna Institute of Medical Sciences Limited — Investor Meet, 17-05-2025: Analysts/Institutional Investor Meet/Con. Call Updates

KIMS Hospitals reported FY25 revenue of INR3,067 Cr (+22% YoY) with EBITDA at INR815 Cr (+24.7%) and stable 26.6% margins. Q4 revenue grew 25.7% to INR801 Cr; EBITDA rose 24.4% to INR203 Cr with 25.3% margins. PAT was INR415 Cr (+23.5%). New units added INR111 Cr revenue but posted EBITDA loss of INR18 Cr, expected to break even within two quarters. Telangana cluster saw margin improvement and expects 20%+ growth; Andhra cluster focused on transplant and oncology ARPOB expansion. ARPOB rose 22.7% YoY; inpatient/outpatient volumes increased 11.6% and 14.1%. FY26 capex planned at INR300-400 Cr with net debt/EBITDA targeted near 1.8x. Margins may face headwinds in FY26 due to new bed ramp-up but mature clusters aim for 27-30% EBITDA margins. Focus remains on geographic expansion, specialty growth, and advanced technology adoption.